> Skip repeated content

Arthroscopic Treatment of Symptomatic Discoid Meniscus in Children: Long-term Follow-up

IRB Number: 14081
(inactive trial)

Institutional Review Board, Hospital for Special Surgery

July 10, 2014

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Daniel W. Green, MD, MS, FAAP, FACS


Scott A. Rodeo, MD
David M. Dare, MD
Jonathan D. Haskel


Long-term follow-up of 28 patients after arthroscopic treatment of a discoid meniscus.

Inclusion/Exclusion Criteria

All patients in Dr. Green’s initial, short-term follow-up, study will be included.

Contact Information

David Dare